Entering text into the input field will update the search result below

Cytokinetics and Fibrocell Science among healthcare gainers; Pulmatrix leads the losers

Mar. 20, 2019 11:04 AM ETCYTK, CLRB, FCSC, VXRT, BPTH, PULM, XNCR, NVRO, MTFB, SLNOBy: Akanksha Bakshi, SA News Editor3 Comments
  • Gainers: Motif Bio (NASDAQ:MTFB) +87%. Nevro (NYSE:NVRO) +34%. Fibrocell Science (NASDAQ:FCSC) +21%. Cytokinetics (NASDAQ:CYTK) +14%. Xencor (NASDAQ:XNCR) +13%.
  • Losers: Pulmatrix (NASDAQ:PULM) -19%. Bio-Path Holdings (NASDAQ:BPTH) -11%. Vaxart (NASDAQ:VXRT) -10%. Cellectar Biosciences (NASDAQ:CLRB-10%. Soleno Therapeutics (NASDAQ:SLNO-9%.

Recommended For You